You are on page 1of 3

Republic of the Philippines

CAVITE STATE UNIVERSITY


(CVSU)
DON SEVERINO DE LAS ALAS CAMPUS
Indang, Cavite
(046)415-0011 (046)415-0012
E-mail: cvsu@asia.com

COLLEGE OF NURSING

GN/BN/CLASSIFCATION/DOSAGE/ ACTION/ INDICATION/ NURSING


ROUTE/FREQUENCY/FORM ADVERSE REACTION RESPONSIBILITIES
Generic Name Action:  Verify and validate
 cefuroxime semi synthetic cephalosporin doctor’s order.
antibiotic that inhibit its cell  Explain to the patient
Brand Name wall synthesis, promoting what the drug is, its
 Ceftin instability action, indication and
Indication: adverse reaction.
Classification  UTI, lower  Before giving the drug
 Cephalosporin respiratory tract and ask the patient if he is
gastrointestinal tract allergic to penicillin
Dosage infection  Monitor the patient for
 750mg  Skin infection signs and symptoms of
 gonorrhoea super infection.
Route:  Tell the patient to
 IV Adverse reaction: report adverse reaction
Diarrhea, nausea, vomiting, promptly
Frequency abdominal pain, ha, rash,  Instruct the patient to
 Q8 hives, vaginitis, mouth ulcers report discomfort at
IV insertion site.
Form  Tell patient to notify
 IV prescriber about loose
stools and diarrhea.

Name of Patient: T.C Age: 14 y/o Date of Admission: 08/11/10


Chief complaint: Hypogastric pain Diagnosis: T/C Acute Abdomen

DRUG STUDY

Student’s Name: Cabiscuelas, Angelica Carla I.


Yr& Sec.: IV-BSN-1
Republic of the Philippines
CAVITE STATE UNIVERSITY
(CVSU)
DON SEVERINO DE LAS ALAS CAMPUS
Indang, Cavite
(046)415-0011 (046)415-0012
E-mail: cvsu@asia.com

COLLEGE OF NURSING

GN/BN/CLASSIFCATION/DOSAGE/ ACTION/ INDICATION/ NURSING


ROUTE/FREQUENCY/FORM CONTRAINDICATION/ RESPONSIBILITIES
ADVERSE REACTION
Generic Name Action:  Verify and validate
 Ranitidine hydrochloride Competitively inhibits action doctor’s order.
of histamine on the H2 at  Monitor V/S
Brand name receptor site of parietal cells,  Assess patient for
 Zantac decreasing gastric acid abdominal pain. Note
secretion. presence of blood in
Classification Indication: emesis, stool, or gastric
 Gastrointestinal tract drugs  Active duodenal and aspirate.
gastric ulcer.  Tell patient to notify if
Dosage  Maintenance therapy presence of adverse effect
 50mg for duodenal o gastric occurs.
ulcer.
Frequency  Pathologic,
 PRN hypersecretory
conditions
Form  Gastro esphageal
 IV reflux disease
 Erosive esophagitis.
 Heartburn

Contraindication:
 Contraindicated in
patients
hypersensitive to
drug and those with
acute porphyria.
 Use cautiously in
patients with hepatic
dysfunction.
 Adjust dosage in
patient with impaired
renal function.
Adverse reaction:
CNS: vertigo, malaise,
headache.
EENT: blurred vision.
Hepatic: jaundice.
Other: burning and itching at
injection site, anaphylaxis,
angiodema.

Student’s Name: Cabiscuelas, Angelica Carla I.


Yr& Sec.: IV-BSN-1
Republic of the Philippines
CAVITE STATE UNIVERSITY
(CVSU)
DON SEVERINO DE LAS ALAS CAMPUS
Indang, Cavite
(046)415-0011 (046)415-0012
E-mail: cvsu@asia.com

COLLEGE OF NURSING

Student’s Name: Cabiscuelas, Angelica Carla I.


Yr& Sec.: IV-BSN-1

You might also like